4//SEC Filing
Orexigen Therapeutics, Inc. 4
Accession 0001181431-15-003650
CIK 0001382911operating
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:34 PM ET
Size
9.3 KB
Accession
0001181431-15-003650
Insider Transaction Report
Form 4
Booth Mark D
Chief Commercial Officer
Transactions
- Sale
Common Stock
2015-02-26$5.68/sh−50,000$284,200→ 3,810 total - Exercise/Conversion
Common Stock
2015-02-26$1.66/sh+50,000$83,000→ 53,810 total - Exercise/Conversion
Stock Option (right to buy)
2015-02-26−50,000→ 563,924 totalExercise: $1.66Exp: 2021-07-24→ Common Stock (50,000 underlying)
Footnotes (5)
- [F1]The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2014.
- [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2014.
- [F3]Weighted average from 16 transactions with prices ranging from $5.66 to $5.85. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares purchased at each separate price.
- [F4]1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) (which option is referred to in this Form 4 as the "Replacement Grant") shall vest on the same day of each one-month period of the Reporting Person's service as an employee, director or consultant following July 25, 2011, so that all of the shares of the stock subject to the option shall be vested on July 25, 2015, subject to the Reporting Person's continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
- [F5]N/A
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001382911
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:34 PM ET
- Size
- 9.3 KB